Bacillus coagulans as a probiotic

Probiotics are live microbial feed additions that improve human or animal health. Their activities are towards improving the composition of the gastrointestinal microbiota in a manner that reduces the risk of disorder. In some cases, probiotics are also used therapeutically. Most probiotics use lactobacilli or bifidobacteria as the main constituents. These produce lactic acid as well as other anti-pathogenic attributes. Traditionally, probiotics are incorporated in dairy products (yoghurts or fermented drinks) or in lyophilised form. Because of stability and viability factors, heated products are not usually a target for probiotic use. This is because they are temperature sensitive. However, a spore-forming genus would have the ability to overcome this limitation. Here, we discuss evidence for the spore-forming Gram-positive bacterium Bacillus coagulans as a probiotic.

[1]  G. Jensen,et al.  GanedenBC30™ cell wall and metabolites: anti-inflammatory and immune modulating effects in vitro , 2010, BMC Immunology.

[2]  A. Maathuis,et al.  Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestine. , 2010, Beneficial microbes.

[3]  M. Kimmel,et al.  A controlled clinical trial to evaluate the effect of GanedenBC(30) on immunological markers. , 2010, Methods and findings in experimental and clinical pharmacology.

[4]  David R Mandel,et al.  Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial , 2010, BMC complementary and alternative medicine.

[5]  Dolin Bj.  Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. , 2009 .

[6]  D. Kalman,et al.  A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms , 2009, BMC gastroenterology.

[7]  A. Schauss,et al.  Safety assessment of a proprietary preparation of a novel Probiotic, Bacillus coagulans, as a food ingredient , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[8]  T. Mitsuoka.  Intestinal flora and aging. , 2009, Nutrition reviews.

[9]  Larysa Hun.  Original Research: Bacillus coagulans Significantly Improved Abdominal Pain and Bloating in Patients with IBS , 2009, Postgraduate medicine.

[10]  Mira Baron.  A patented strain of Bacillus coagulans increased immune response to viral challenge. , 2009, Postgraduate medicine.

[11]  R. Hutkins.  Cultured Dairy Products , 2006 .

[12]  Francisco Guarner,et al.  Enteric Flora in Health and Disease , 2006, Digestion.

[13]  F. Guarner,et al.  Gut flora in health and disease , 2003, The Lancet.

[14]  G. Gibson,et al.  Probiotics as modulators of the gut flora , 2002, British Journal of Nutrition.

[15]  S. Cutting,et al.  Bacillus Probiotics: Spore Germination in the Gastrointestinal Tract , 2002, Applied and Environmental Microbiology.

[16]  F. Shanahan,et al.  In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. , 2001, The American journal of clinical nutrition.

[17]  P. Marteau,et al.  Protection from gastrointestinal diseases with the use of probiotics. , 2001, The American journal of clinical nutrition.

[18]  R. Rolfe.  The role of probiotic cultures in the control of gastrointestinal health. , 2000, The Journal of nutrition.

[19]  G. Tannock.  Probiotics A critical review , 1999 .

[20]  B. Goldin.  Health benefits of probiotics , 1998, British Journal of Nutrition.

[21]  M. Roberfroid,et al.  Functional food science and gastrointestinal physiology and function , 1998, British Journal of Nutrition.

[22]  S. Bengmark.  Ecological control of the gastrointestinal tract. The role of probiotic flora , 1998, Gut.

[23]  G R Gibson,et al.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. , 1995, The Journal of nutrition.

[24]  C. Tancrède.  Role of human microflora in health and disease , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[25]  G. Macfarlane,et al.  The control and consequences of bacterial fermentation in the human colon. , 1991, The Journal of applied bacteriology.

[26]  R. Fuller,et al.  Probiotics in man and animals. , 1989, The Journal of applied bacteriology.

[27]  G. Gibson,et al.  Prebiotics: development and application , 2006 .

[28]  G. Macfarlane,et al.  The Human Colonic Microbiota , 1999 .

[29]  G. Tannock.  A fresh look at the intestinal microflora. , 1999 .

[30]  Glenn R. Gibson,et al.  Prebiotics, probiotics and human gut microbiology , 1999 .

[31]  M. Roberfroid,et al.  Colonic microbiota, nutrition, and health , 1999 .

[32]  R. Fuller.  Probiotics 2 : applications and practical aspects , 1997 .

[33]  R. Fuller.  Probiotics : the scientific basis , 1992 .